TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies September 25, 1998
TCL Archive NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08. September 21, 2007